Octapharma Ltd - Octaplas LG
Norfolk and Norwich University Hospitals NHS Foundation TrustcontractContracts Finder ↗Ref CF-1642900D0O000000rwimUAAcomplete
Estimated value
£53k
Awarded value
£53k
Awarded 29 Apr 2023
Suppliers
1
Lots
1
1 awarded
Published
14 Jun 2023
Deadline 30 Apr 2023
Description
Octaplas LG
Scope
- Reference
- CF-1642900D0O000000rwimUAA
- Total value
- £52,500 excluding VAT
- Commercial tool
- Standalone contract
- Contract dates
- 30 Apr 2023 to 29 Apr 2024
- CPV classifications
- 33950000
Submission & procedure
- Submission deadline
- 30 Apr 2023, 11:00 am
Award details
Awarded supplier(s), contract period and value as published in the award notice.
Awarded value
£53k
Award date
29 Apr 2023
Contract start
30 Apr 2023
Contract end
29 Apr 2024
Awarded to
Awarded suppliers· 1 supplier
Awarded 29 Apr 2023 · Contract period 30 Apr 2023 — 29 Apr 2024
Award value
£53k
Other contracts from Norfolk and Norwich University Hospitals NHS Foundation Trust
Full notice and award history for this contracting authority is on the buyer profile.
Other contracts awarded to Octapharma Limited· 10
Cross-buyer view of this supplier's public-sector wins.
| Title | Type | Value | Published |
|---|---|---|---|
| Octapharma - Blood Disorder Treatment products (inc Haemophilia A & B) | contract | £72k | 12 Mar 2025 |
| NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin | contract | — | 20 Jan 2025 |
| Human Derived Blood Products | contract | — | 28 Aug 2024 |
| NHS Framework - Blood Disorders including Haemophilia A and B - July 2024 | contract | — | 11 Jun 2024 |
| Octaplex Treatment | contract | £100k | 10 May 2023 |
| Blood product required for the treatment of TTP patients | contract | £98k | 03 Aug 2022 |
| NHS National Framework Agreement for the supply of products for the treatment of Bleeding Disorders, including Haemophilia B | contract | — | 04 Jul 2022 |
| Human Normal Immunoglobulin and Anti-D Immunoglobulin | contract | £64.3m | 23 Jul 2021 |
| NHS Framework Agreement for the supply of Human Normal Immunoglobulin and Anti-D Immunoglobulin | contract | — | 22 Jul 2021 |
| NHS Framework Agreement for the Supply of Human Normal Immunoglobulin (Panzyga) | contract | — | 11 Jun 2021 |